#430 DB-1303, a HER2-targeting ADC, for patients with advanced/metastatic endometrial cancer: preliminary clinical results from an ongoing phase 1/2a trial (NCT05150691)

Oral Sessions, 2023

Proceedings article published in 2023 by Kathleen Moore, Vicky Makker, Oladapo Yeku, Bhavana Pothuri, Whitfield Growden, Erika Hamilton, Fernanda Musa, Li Wang, Xiumin Li, Natalie Godbee, Weidi Shen, Liming Liu, Rong Shi, Shengxue Liu, Wei Gu and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload